Buprenorphine Addiction Symptoms & Treatment

There are numerous strategies for addressing addiction. One such approach is medication-assisted treatment (MAT), which utilizes medications to assist individuals in recovery by preventing withdrawal-related health issues and reducing the chances of relapse. Buprenorphine is commonly included in MAT programs. However, it is important to note that, like many prescription medications, buprenorphine may have adverse effects if not used as intended.

Buprenorphine, a partial opioid agonist, acts on the same brain receptors, referred to as opioid receptors, as other opioids such as heroin. However, it differs in that it does not induce the same intense feelings of euphoria. Through clinical testing, researchers discovered the potential of buprenorphine for treating narcotic addiction, although it was not FDA-approved for this purpose until the early 2000s.

In present times, buprenorphine is commonly combined with naloxone to form a brand-name medication called Suboxone. Suboxone is widely utilized in MAT programs to address opioid and alcohol use disorders. Other brand names for buprenorphine or buprenorphine-combination medications include Bunavail and Zubsolv.

MAT programs for both alcohol use disorder and opioid use disorder may incorporate buprenorphine into a comprehensive treatment plan that encompasses counseling therapies and other conventional approaches. In the case of opioid addiction, buprenorphine functions as an opioid substitute, inhibiting the full interaction of more dangerous opioids with brain receptors. This effectively hinders the pleasurable sensations induced by substances like heroin, morphine, and other opioids. Simultaneously, the medication reduces the adverse effects of withdrawal, including the intense cravings that pose a challenge for many highly motivated recovery patients in their quest to avoid relapse.

Medication-assisted treatment, a well-researched and FDA-approved approach for treating opioid addiction, is highly recommended by the Substance Abuse and Mental Health Services Administration (SAMHSA) and other reputable health organizations. However, it is important to acknowledge that buprenorphine addiction treatment still carries its own risks. Being partial opioid agonists, buprenorphine and Suboxone do have the potential for addiction. Nevertheless, the risk of addiction is significantly lower compared to other types of opioids. When incorporated into a comprehensive addiction treatment plan, buprenorphine assists in a gradual and safe withdrawal from more hazardous opioids. Consequently, individuals in rehabilitation can stabilize their physical and mental well-being while simultaneously working towards rebuilding relationships and their lives on various levels.

When patients follow the proper administration of a MAT program, they can expect minimal, if any, withdrawal symptoms. After a period of maintenance, which can range from several months to several years, a gradual tapering-off process will commence. Over the course of approximately 60 days, the dosage of buprenorphine (or Suboxone) will be systematically reduced on a weekly basis. This gradual and consistent approach promotes the patient's overall well-being and diminishes the chances of relapse.

However, if the medication is misused or an individual abruptly stops taking it, withdrawal symptoms may ensue. These symptoms may encompass:

The impact of opioids on the brain varies from person to person. As someone continues to use buprenorphine over time, their body becomes more accustomed to the substance, making withdrawal more challenging. The severity of withdrawal symptoms is also influenced by the dosage of buprenorphine being used and the duration of abuse.

In severe cases, a buprenorphine overdose can lead to respiratory depression, coma, brain damage, and death. If you suspect someone has overdosed on buprenorphine, Suboxone, or any other substance, call 911 immediately and stay with the person until help arrives.

All approved treatments for other forms of opioid use disorder can effectively address buprenorphine addiction as well. If an individual develops an addiction to buprenorphine due to medication-assisted treatment or illicit attempts to manage opioid withdrawal, they may not be suitable for a medication-assisted treatment program. Nonetheless, each person's circumstances vary, and only a qualified physician can assess and make that decision.

About Changing Echoes rehab program

If you're struggling with a morphine addiction or any form of buprenorphine dependency, seeking assistance is crucial. At Changing Echoes, we provide personalized programs tailored to address your specific challenges and circumstances. Our state-of-the-art facilities and cutting-edge techniques for treating substance use disorders can guide you back to a healthier path. Reach out to Changing Echoes today at (800) 633-7066.